DNM2 and Alzheimer disease: Stable DNM2 recruitment during CME correlates well with CLTC lifetime [128], while a risk allele at rs892086 is associated with reduced expression of DNM2 mRNA in the hippocampus in AD patients compared with non-demented controls [129].